ATC Group: J01CE02 Phenoxymethylpenicillin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J01CE02 in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J01 Antibacterials for systemic use
3 J01C Beta-lactam antibacterials, penicillins
4 J01CE Beta-lactamase sensitive penicillins
5 J01CE02 Phenoxymethylpenicillin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 2 g

Active ingredients in J01CE02

Active Ingredient Description
Phenoxymethylpenicillin

Phenoxymethylpenicillin is a broad spectrum beta-lactam antibiotic. Phenoxymethylpenicillin binds to penicillin-binding proteins located on the inner membrane of the bacterial cell wall. Phenoxymethylpenicillin binds to and inactivates these proteins resulting in weakening of the bacterial cell wall and lysis.

Related product monographs

Title Information Source Document Type  
PENOPEN Film-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC

Medicines in this ATC group

Australia (AU)

Brazil (BR)

Cyprus (CY)

Estonia (EE)

Finland (FI)

France (FR)

Ireland (IE)

Lithuania (LT)

Malta (MT)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

Poland (PL)

Romania (RO)

Singapore (SG)

Tunisia (TN)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.